163 related articles for article (PubMed ID: 37522494)
21. Recent progress in melasma pathogenesis.
Lee AY
Pigment Cell Melanoma Res; 2015 Nov; 28(6):648-60. PubMed ID: 26230865
[TBL] [Abstract][Full Text] [Related]
22. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
Rendon MI; Barkovic S
J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp Examination.
Amatya B
Dermatol Pract Concept; 2022 Feb; 12(1):e2022030. PubMed ID: 35223174
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients.
Li YH; Chen JZ; Wei HC; Wu Y; Liu M; Xu YY; Dong GH; Chen HD
Dermatol Surg; 2008 May; 34(5):693-700; discussion 700-1. PubMed ID: 18318729
[TBL] [Abstract][Full Text] [Related]
25. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
[TBL] [Abstract][Full Text] [Related]
26. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
27. Response to narrow-band UVB--vitiligo-melasma versus vitiligo: a comparative study.
Sharma P; Pai HS; Pai GS; Kuruvila M; Kolar R
Am J Clin Dermatol; 2011 Apr; 12(2):127-32. PubMed ID: 21348543
[TBL] [Abstract][Full Text] [Related]
28. Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure.
Duteil L; Cardot-Leccia N; Queille-Roussel C; Maubert Y; Harmelin Y; Boukari F; Ambrosetti D; Lacour JP; Passeron T
Pigment Cell Melanoma Res; 2014 Sep; 27(5):822-6. PubMed ID: 24888214
[TBL] [Abstract][Full Text] [Related]
29. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
Brown AS; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore.
Goh CL; Dlova CN
Singapore Med J; 1999 Jul; 40(7):455-8. PubMed ID: 10560271
[TBL] [Abstract][Full Text] [Related]
31. African ancestry is associated with facial melasma in women: a cross-sectional study.
D'Elia MP; Brandão MC; de Andrade Ramos BR; da Silva MG; Miot LD; Dos Santos SE; Miot HA
BMC Med Genet; 2017 Feb; 18(1):17. PubMed ID: 28212612
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of glycolic acid facial peel in Indian women with melasma.
Javaheri SM; Handa S; Kaur I; Kumar B
Int J Dermatol; 2001 May; 40(5):354-7. PubMed ID: 11555002
[TBL] [Abstract][Full Text] [Related]
33. A study of efficacy and safety of high-intensity focused ultrasound for the treatment of melasma in Asians: A single-blinded, randomized, split-face, pilot study.
Vachiramon V; Iamsumang W; Chanasumon N; Thadanipon K; Triyangkulsri K
J Cosmet Dermatol; 2020 Feb; 19(2):375-381. PubMed ID: 31173464
[TBL] [Abstract][Full Text] [Related]
34. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
Rendon M; Dryer L
J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
[TBL] [Abstract][Full Text] [Related]
35. Melasma in Latin Americans.
Perez M; Luke J; Rossi A
J Drugs Dermatol; 2011 May; 10(5):517-23. PubMed ID: 21533299
[TBL] [Abstract][Full Text] [Related]
36. Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study.
Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Marques MEA; Miot HA
Int J Cosmet Sci; 2018 Aug; 40(4):420-424. PubMed ID: 29846953
[TBL] [Abstract][Full Text] [Related]
37. Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring.
Rusciani A; Motta A; Rusciani L; Alfano C
J Drugs Dermatol; 2005; 4(6):770-4. PubMed ID: 16302566
[TBL] [Abstract][Full Text] [Related]
38. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
39. A new proprietary gel containing glabridin, andrographolide, and apolactoferrin improves the appearance of epidermal melasma in adult women: A 6-month pilot, uncontrolled open-label study.
Cantelli M; Ferrillo M; Donnarumma M; Emanuele E; Fabbrocini G
J Cosmet Dermatol; 2020 Jun; 19(6):1395-1398. PubMed ID: 31541594
[TBL] [Abstract][Full Text] [Related]
40. Natural options for management of melasma, a review.
Nomakhosi M; Heidi A
J Cosmet Laser Ther; 2018; 20(7-8):470-481. PubMed ID: 29461133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
